Goodsurance
ES

Policy & oversight

Traditional Medicare Required Prior Authorization for Certain Services in Six States for the First Time Starting January 2026, KFF Finds

A KFF examination of the WISeR Model, active in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington, found it targets services whose spending grew about 400 percent between 2019 and 2024.

By the Goodsurance editorial teamSeptember 21, 2026

A KFF analysis published in February 2026 examined the WISeR Model, a Center for Medicare and Medicaid Innovation program that introduced prior authorization requirements into traditional Medicare for the first time.

The model, whose full name is Wasteful and Inappropriate Service Reduction, launched January 1, 2026 in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. Traditional Medicare has historically not required prior authorization for covered services, a structural difference from Medicare Advantage plans, which have used advance approval as a cost-management tool for many years. WISeR represents the first large-scale use of prior authorization in the traditional Medicare fee-for-service program.

Traditional Medicare now requires prior authorization for certain procedures in 6 states for the first time, under a federal model active since January 2026, KFF reports.

Services subject to prior authorization under WISeR include skin substitute wound care products, several orthopedic pain management procedures such as epidural steroid injections and cervical fusion, electrical nerve stimulator implants, incontinence control devices, and services related to impotence diagnosis and treatment.

KFF found that these services collectively accounted for about 12.3 billion dollars, or 5.3 percent of all Medicare Part B spending in 2024. Spending on WISeR-targeted services had grown about 400 percent between 2019 and 2024. Skin substitutes alone represented 83 percent of that category's spending. KFF estimated that about 207,500 beneficiaries in the six WISeR states would be subject to the new requirement.

The analysis also noted that a concurrent nationwide Medicare payment reform for skin substitutes, separate from WISeR, was projected to reduce Medicare spending on those products by nearly 90 percent in 2026, a change that may exceed WISeR's own fiscal impact. Providers in WISeR states had already reported implementation difficulties in the early months of the model.

In plain words

Starting January 1, 2026, some Medicare patients in six states need to get approval before they can receive certain medical treatments. This is called prior authorization.

The six states are Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington.

This is new for traditional Medicare. In the past, traditional Medicare did not usually require pre-approval for covered services. Medicare Advantage plans have had this type of requirement for many years, but not traditional Medicare.

The treatments that now need approval in these states include wound care patches, some back pain injections, spinal procedures, nerve stimulators, and a few others.

A study group called KFF looked at this new rule. They found spending on these services grew very fast, about 400 percent in just five years. About 207,500 people in those six states may need to go through the new approval process.

If you live in one of these states and need one of these treatments, ask your doctor about getting prior authorization before your appointment.

Source: KFF
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

Medicare Finalizes 2027 Doctor Pay Rule, Banning Remote Monitoring Vendors and Setting a MIPS Retirement Date

A rule finalized November 4 locks in a small physician payment cut, prohibits Medicare billing for remote monitoring services handled by outside vendors, and officially schedules the end of the MIPS quality program in 2031.

November 5, 2026

Policy & oversight

Democrats Win Back Congress, Naming Medicare Oversight and Medicaid Reversal as Top Health Priorities

Democrats gained control of the House and Senate on November 3, with health care ranking among the leading voter concerns. Their declared priorities include Medicaid spending cuts enacted in 2025, Medicare Advantage insurer oversight, and drug pricing, though President Trump retains veto power.

November 5, 2026

Policy & oversight

CMS Holds Public Meeting Today on Which New Medical Devices Should Get Medicare Billing Codes

The agency is taking public input on prosthetics, wound care products, and other supplies seeking HCPCS Level II billing codes, with final coverage decisions expected in February 2027 and effective April 1.

November 2, 2026

Policy & oversight

Glendale Doctor Gets 15 Years for Billing Medicare 45 Million Dollars for Botox Shots She Never Gave

A California physician who submitted claims for Botox injections that were never provided, including on days her clinic was closed and while she was on vacation, was sentenced October 30 to 15 years in federal prison.

November 1, 2026

Policy & oversight

West Virginia Receives More Than 19 Million Dollars in Federal Rural Health Grants for Telehealth, Drone Drug Delivery, and Mental Health

Eleven awards under the Rural Health Transformation Program will fund mobile clinics, drone-delivered medical supplies, remote eye care, and nursing apprenticeships, as part of West Virginia's nearly 199 million dollar share of the federal initiative.

October 31, 2026

Policy & oversight

Federal Judge Blocks Part of Medicaid Work Rule That Narrowed Who Counts as Medically Frail

A U.S. district court found that CMS wrote an unlawfully restrictive definition of "medically frail" for the new Medicaid work requirements, blocking its enforcement in 25 states and the District of Columbia. The ruling directly touches Medicare beneficiaries who also rely on Medicaid.

October 31, 2026